山东药玻
(600529)
| 流通市值：123.43亿 | | | 总市值：123.43亿 |
| 流通股本：6.64亿 | | | 总股本：6.64亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 3,249,212,247.58 | 2,280,395,300.46 | 1,219,063,985.04 | 4,474,018,978.75 |
| 营业收入 | 3,249,212,247.58 | 2,280,395,300.46 | 1,219,063,985.04 | 4,474,018,978.75 |
| 二、营业总成本 | 2,617,764,839.56 | 1,815,722,108.72 | 960,424,944.76 | 3,533,710,798.9 |
| 营业成本 | 2,199,193,033.65 | 1,530,906,053.34 | 822,101,029.11 | 2,983,735,053.33 |
| 税金及附加 | 43,325,307.24 | 32,149,538.18 | 15,842,271.92 | 51,340,606.36 |
| 销售费用 | 77,469,046.25 | 53,892,998.46 | 29,277,954.15 | 107,683,043.93 |
| 管理费用 | 169,768,253.24 | 112,759,285.62 | 51,384,369.95 | 232,409,811.05 |
| 研发费用 | 113,134,114.78 | 74,976,290.88 | 36,717,625.5 | 174,795,365.98 |
| 财务费用 | 14,875,084.4 | 11,037,942.24 | 5,101,694.13 | -16,253,081.75 |
| 其中:利息费用 | 850,502.33 | 594,559.02 | 706,059.83 | 514,193.21 |
| 其中:利息收入 | 11,654,848.43 | 7,891,784.3 | 3,868,752.38 | 12,852,652.03 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 11,487,094.08 | 4,381,715.52 | 2,138,682.51 | 9,136,242.46 |
| 加:投资收益 | 9,732,431.35 | 9,582,895.86 | 4,664,897.49 | 17,548,332.44 |
| 资产处置收益 | 4,038,279.16 | 2,495,584.87 | 37,608.29 | 1,452,467.75 |
| 资产减值损失(新) | -45,957,940.46 | -33,853,345.47 | -18,152,583.1 | -156,894,172.13 |
| 信用减值损失(新) | 3,410,962.21 | -2,196,502.03 | -10,627,038.12 | 3,946,360.61 |
| 其他收益 | 19,384,437.62 | 10,900,843.88 | 5,093,497.23 | 22,463,415.96 |
| 四、营业利润 | 633,542,671.98 | 455,984,384.37 | 241,794,104.58 | 837,960,826.94 |
| 加:营业外收入 | 3,644,156.96 | 3,370,641.5 | 260,330.19 | 2,349,125.79 |
| 减:营业外支出 | 8,229,595.24 | 6,999,837.79 | 2,824,946.99 | 9,481,883.94 |
| 五、利润总额 | 628,957,233.7 | 452,355,188.08 | 239,229,487.78 | 830,828,068.79 |
| 减:所得税费用 | 108,695,185.18 | 81,487,236.42 | 38,023,467.65 | 141,202,028.13 |
| 六、净利润 | 520,262,048.52 | 370,867,951.66 | 201,206,020.13 | 689,626,040.66 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 520,262,048.52 | 370,867,951.66 | 201,206,020.13 | 689,626,040.66 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 520,262,048.52 | 370,867,951.66 | 201,206,020.13 | 689,626,040.66 |
| 扣除非经常损益后的净利润 | 492,902,521.84 | 354,428,900.51 | 194,124,328.97 | 658,460,201.17 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.78 | 0.56 | 0.3 | 1.04 |
| (二)稀释每股收益 | 0.78 | 0.56 | 0.3 | 1.04 |
| 九、综合收益总额 | 520,262,048.52 | 370,867,951.66 | 201,206,020.13 | 689,626,040.66 |
| 归属于母公司股东的综合收益总额 | 520,262,048.52 | 370,867,951.66 | 201,206,020.13 | 689,626,040.66 |
| 公告日期 | 2026-10-27 | 2026-08-25 | 2026-04-25 | 2026-03-07 |
| 审计意见(境内) | | | | 标准无保留意见 |